|
KIAA1430 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.848200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.934400E-01 |
| Normal-vs-Stage2 |
6.418800E-01 |
| Normal-vs-Stage3 |
1.212400E-01 |
| Normal-vs-Stage4 |
3.624300E-02 |
| Stage1-vs-Stage2 |
9.181400E-01 |
| Stage1-vs-Stage3 |
1.227650E-02 |
| Stage1-vs-Stage4 |
4.042000E-03 |
| Stage2-vs-Stage3 |
2.025600E-01 |
| Stage2-vs-Stage4 |
1.197210E-01 |
| Stage3-vs-Stage4 |
6.390800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.528200E-01 |
| Normal-vs-AfricanAmerican |
3.284700E-03 |
| Normal-vs-Asian |
2.107000E-01 |
| Caucasian-vs-AfricanAmerican |
2.175900E-03 |
| Caucasian-vs-Asian |
4.071400E-01 |
| AfricanAmerican-vs-Asian |
2.929900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.145600E-01 |
| Normal-vs-Female |
9.067800E-01 |
| Male-vs-Female |
6.817200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.403200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.808400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.808000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.870800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.537600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.843400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.438000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.723600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.232200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.644400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.932200E-01 |
| Normal-vs-Grade 2 |
1.251050E-01 |
| Normal-vs-Grade 3 |
1.609360E-01 |
| Normal-vs-Grade 4 |
1.078170E-03 |
| Grade 1-vs-Grade 2 |
8.910400E-01 |
| Grade 1-vs-Grade 3 |
1.744220E-01 |
| Grade 1-vs-Grade 4 |
1.102290E-02 |
| Grade 2-vs-Grade 3 |
2.997500E-03 |
| Grade 2-vs-Grade 4 |
3.63749999998664E-06 |
| Grade 3-vs-Grade 4 |
3.025900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.540900E-03 |
| Normal-vs-ccB subtype |
1.914230E-01 |
| ccA subtype-vs-ccB subtype |
1.159010E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.375600E-01 |
| Normal-vs-N1 |
9.311800E-01 |
| N0-vs-N1 |
8.367000E-01 |
|
|
